AU2001261671A1 - Method of identifying critical points within protein-protein interactions - Google Patents

Method of identifying critical points within protein-protein interactions

Info

Publication number
AU2001261671A1
AU2001261671A1 AU2001261671A AU6167101A AU2001261671A1 AU 2001261671 A1 AU2001261671 A1 AU 2001261671A1 AU 2001261671 A AU2001261671 A AU 2001261671A AU 6167101 A AU6167101 A AU 6167101A AU 2001261671 A1 AU2001261671 A1 AU 2001261671A1
Authority
AU
Australia
Prior art keywords
protein
critical points
identifying critical
interactions
protein interactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261671A
Inventor
Fred E. Cohen
Thomas L. James
Kiyotoshi Kaneko
Stanley B Prusiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU2001261671A1 publication Critical patent/AU2001261671A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
AU2001261671A 2000-05-16 2001-05-15 Method of identifying critical points within protein-protein interactions Abandoned AU2001261671A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57298000A 2000-05-16 2000-05-16
US09572980 2000-05-16
PCT/US2001/015832 WO2001087911A1 (en) 2000-05-16 2001-05-15 Method of identifying critical points within protein-protein interactions

Publications (1)

Publication Number Publication Date
AU2001261671A1 true AU2001261671A1 (en) 2001-11-26

Family

ID=24290144

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261671A Abandoned AU2001261671A1 (en) 2000-05-16 2001-05-15 Method of identifying critical points within protein-protein interactions

Country Status (3)

Country Link
EP (1) EP1290004A1 (en)
AU (1) AU2001261671A1 (en)
WO (1) WO2001087911A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1572937B1 (en) 2002-04-09 2012-02-08 The Scripps Research Institute Motif-grafted hybrid polypeptides and uses thereof

Also Published As

Publication number Publication date
EP1290004A1 (en) 2003-03-12
WO2001087911A1 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
AU2002303584A1 (en) Method for identifying comparable instruments
AU2002361342A1 (en) System and method for selecting access point
GB0016154D0 (en) Method of selecting an object
AU2002222172A1 (en) Method of retrieving entities
AU2001241075A1 (en) Method of anticipating interaction between proteins
AU2002302243A1 (en) Method for determination of co-occurences of attributes
AU2002216080A1 (en) Method for determining competing risks
AU2002338428A1 (en) Methods and systems for identifying proteins
AU2001281269A1 (en) Search system and method
AU2002214286A1 (en) Method of profiling protein
AU2002221740A1 (en) Method for analyzing proteins
AU2002219900A1 (en) Minimal identification of features
AU2001271841A1 (en) Methods for identifying combinations of drugs
AU2002241188A1 (en) Methods for systematic identification of protein - protein interactions
AU2001278135A1 (en) Method of identifying immunosuppressive agents
AU2001237530A1 (en) Method
AU2002246912A1 (en) Receptor-binding compounds and methods for identifying them
AU2001241636A1 (en) Halotherapy method
AU2001261671A1 (en) Method of identifying critical points within protein-protein interactions
AU2001253092A1 (en) Method for detection of truncated proteins
AUPR748601A0 (en) An object identification method
AU2001297734A1 (en) Method of managing data
AU2000277689A1 (en) Electronic trade method
AU2001232127A1 (en) Identification method
AU2001235770A1 (en) Method